{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Lexington&page=21&state=Kentucky", "query": { "state": "Kentucky", "city": "Lexington", "page": 21 }, "page_size": 10 }, "pagination": { "page": 21, "page_size": 10, "total_count": 4514, "total_pages": 452, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Lexington&page=22&state=Kentucky&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Lexington&page=20&state=Kentucky&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T13:44:38.884Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04137107", "title": "Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Stage II Colorectal Cancer AJCC v8", "Stage III Colorectal Cancer AJCC v8" ], "interventions": [ { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Duloxetine Hydrochloride", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 220, "start_date": "2020-06-17", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-01-26", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 792, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 525 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04137107" }, { "nct_id": "NCT00424892", "title": "Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Desvenlafaxine Sustained Release", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": null, "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2007-12-06", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 59, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Phoenix, Arizona + 52 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00424892" }, { "nct_id": "NCT02708134", "title": "Quality of Pediatric Resuscitation in a Multicenter Collaborative", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiac Arrest", "Cardiopulmonary Arrest" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "0 Years to 18 Years" }, "enrollment_count": 7000, "start_date": "2016-05-02", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 42, "location_summary": "Los Angeles, California • Madera, California • Orange, California + 33 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Madera", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02708134" }, { "nct_id": "NCT01756729", "title": "Post-approval Study of NovoTTF-100A in Recurrent GBM Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Recurrent Glioblastoma Multiforme" ], "interventions": [ { "name": "NovoTTF-100A", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "NovoCure Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 13, "start_date": "2012-12", "completion_date": "2018-01", "has_results": false, "last_update_posted_date": "2016-03-02", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01756729" }, { "nct_id": "NCT04908202", "title": "A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Deucravacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 670, "start_date": "2021-07-13", "completion_date": "2027-06-03", "has_results": true, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 33, "location_summary": "Gilbert, Arizona • Jonesboro, Arkansas • Fontana, California + 30 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fontana", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04908202" }, { "nct_id": "NCT05675410", "title": "A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bleomycin Sulfate", "type": "BIOLOGICAL" }, { "name": "Brentuximab Vedotin", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Dacarbazine", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Etoposide Phosphate", "type": "DRUG" }, { "name": "Fludeoxyglucose F-18", "type": "OTHER" }, { "name": "Involved-site Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Procarbazine Hydrochloride", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Vinblastine Sulfate", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL", "DRUG", "OTHER", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "5 Years to 60 Years" }, "enrollment_count": 1875, "start_date": "2023-05-11", "completion_date": "2031-04-28", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 402, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 297 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05675410" }, { "nct_id": "NCT00513292", "title": "Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HER2/Neu Positive", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Epirubicin Hydrochloride", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Therapeutic Conventional Surgery", "type": "PROCEDURE" }, { "name": "Trastuzumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 280, "start_date": "2007-07", "completion_date": "2013-02-21", "has_results": true, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 114, "location_summary": "Mobile, Alabama • Castro Valley, California • Greenbrae, California + 83 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Castro Valley", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "Hayward", "state": "California" }, { "city": "Pleasanton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00513292" }, { "nct_id": "NCT01253200", "title": "Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrial Flutter" ], "interventions": [ { "name": "Blazer® Open-Irrigated Ablation Catheter", "type": "DEVICE" }, { "name": "Control Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 302, "start_date": "2011-01", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2018-03-19", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Fullerton, California • Sacramento, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fullerton", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01253200" }, { "nct_id": "NCT05128344", "title": "A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spasms, Infantile" ], "interventions": [ { "name": "AMZ002 injectable solution, 0.5mg/mL", "type": "DRUG" }, { "name": "Vigabatrin, oral", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amzell", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "2 Months to 24 Months" }, "enrollment_count": 0, "start_date": "2023-04", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2023-04-20", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 12, "location_summary": "Aurora, Colorado • Miami, Florida • Orlando, Florida + 8 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05128344" }, { "nct_id": "NCT07084064", "title": "Families Moving Together Curriculum", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Physical Activities", "Families" ], "interventions": [ { "name": "Families Moving Together", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Deirdre Dlugonski", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "ALL", "summary": "3 Years and older" }, "enrollment_count": 58, "start_date": "2025-06-05", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-21T13:44:38.884Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT07084064" } ] }